Skip to main content

03-03-2018 | Hematologic cancers | Article

Sexual health in patients with hematological malignancies: a neglected issue

Supportive Care in Cancer

Authors: Pasquale Niscola, Fabio Efficace, Elisabetta Abruzzese

Publisher: Springer Berlin Heidelberg


Current evidence, although limited, outlines that sexual dysfunction may represent a prominent part of the symptom burden experienced by the patients with hematologic malignancies (HM). However, despite their presumed negative effects on quality of life (QoL), sexual health is not typically considered in the QoL assessment of HM patients. In addition, very few studies have been conducted in this area. Therefore, it would be important to further investigate how newer drugs developed in recent years for patients with HM, including targeted therapies and impact on sexual health, and how this influence overall patients’ QoL outcomes.

Please log in to get access to this content

Related topics